Show Summary Details
Page of

Percutaneous coronary intervention 

Percutaneous coronary intervention
Percutaneous coronary intervention

Pasi P. Karjalainen

, Kurt Huber

, Gérard Helft

, Andrea Rubboli

, and Eric Eeckhout

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 30 October 2020

Percutaneous coronary intervention with stent implantation is the most widely used mode of myocardial revascularization. To limit and balance the risk of major adverse cardiac events, stent thrombosis, and bleeding, several peri- and post-procedural issues need to be properly addressed. Optimal pharmacological management and technique are warranted to avoid peri-procedural bleeding. Optimal duration and management of dual antiplatelet therapy are warranted to avoid post-procedural stent thrombosis. Proper stent selection is essential for gaining the greatest patient benefit following major adverse cardiac events(MACE) and stent thrombosis, while limiting the incidence of bleeding complications.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.